Company Filing History:
Years Active: 2001-2006
Title: The Innovations of Daniel Adourel
Introduction
Daniel Adourel is an accomplished inventor based in Woodinville, WA (US). He has made significant contributions to the field of biotechnology, particularly in the area of enzyme activity related to lysophosphatidic acid acyltransferase. With a total of 4 patents to his name, Adourel's work has implications for various therapeutic applications.
Latest Patents
Among his latest patents are the Human lysophosphatidic acid acyltransferase gamma-1 polypeptide and the Human lysophosphatidic acid acyltransferase gamma-2 polypeptide. These polypeptides are obtained through the expression of encoding cDNA sequences, which exhibit the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase. His innovative work in this area showcases the potential for advancements in medical treatments.
Career Highlights
Daniel Adourel has worked with notable companies such as Cell Therapeutics, Inc. and Cell Therapeutics, Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of biotechnological research and applications.
Collaborations
Throughout his career, Adourel has collaborated with esteemed colleagues, including David W. Leung and David M. Hollenback. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Daniel Adourel's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for future innovations in medical science.